Provided by Tiger Trade Technology Pte. Ltd.

CAR-T Concept

1,772.39
+20.431.17%
Number of Gainers:2
Number of Losers:- -
Number of Flat:- -
PE:- -
High:1,774.11
Open:1,750.92
Low:1,750.92
Close:1,751.96
Volume:7.38M
Turnover:1.01B
Market Cap:456.73B
Float Cap:442.41B

Loading ...

Experimental treatments could help US Ebola patient

Reuters
·
Yesterday

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Yesterday

FDA Grants Accelerated Approval to Gilead’s Hepcludex® (Bulevirtide-Gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (Hdv)

THOMSON REUTERS
·
Yesterday

US FDA approves Gilead's drug for deadly liver infection

Reuters
·
Yesterday

FDA: Approved Hepcludex Injection to Treat Chronic Hepatitis Delta Virus Infection in Adults Without Cirrhosis or With Compensated Cirrhosis

THOMSON REUTERS
·
Yesterday

FACTBOX-Bundibugyo Ebola vaccines and treatments in development

Reuters
·
Yesterday

China's commerce ministry holds meeting with foreign pharmaceutical firms

Reuters
·
May 22

China Commerce Ministry Says Companies Include Eli Lilly, Sanofi, Novartis, Merck - Statement

THOMSON REUTERS
·
May 22

WHO raises risk of Ebola outbreak in Congo to 'very high' at national level

Reuters
·
May 22

BRIEF-Gilead Receives CHMP Positive Opinion For Trodelvy® In First-Line Metastatic Triple-Negative Breast Cancer

Reuters
·
May 22

Gilead receives positive CHMP opinion for Trodelvy in TNBC

TIPRANKS
·
May 22

Gilead Gets Positive Opinion From European Regulators on Breast-Cancer Treatment

Dow Jones
·
May 22

Gilead Receives Chmp Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for Pd-(L)1 Inhibitors

THOMSON REUTERS
·
May 22

Kite presents updated Phase 1 data for KITE-753 CAR-T in relapsed B-cell lymphoma

Reuters
·
May 22

New Asco and Eha 2026 Data Demonstrate Gilead and Kite’s Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology

THOMSON REUTERS
·
May 22

Gilead Sciences Closes Tubulis Acquisition

MT Newswires Live
·
May 21

Gilead renews five-year collaboration with World Health Organization

TIPRANKS
·
May 21

Gilead Sciences Renews WHO Collaboration to Help Treat Visceral Leishmaniasis

MT Newswires Live
·
May 21

Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

THOMSON REUTERS
·
May 21

Gilead Sciences Launches New $3 Billion Senior Notes

TIPRANKS
·
May 21